MARCOS GONZÁLEZ DÍAZ-rekin lankidetzan egindako argitalpenak (15)

2017

  1. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

    Leukemia, Vol. 31, Núm. 10, pp. 2094-2103

2012

  1. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation

    Leukemia, Vol. 26, Núm. 8, pp. 1821-1828

2011

  1. Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats

    Leukemia, Vol. 25, Núm. 9, pp. 1467-1470

2007

  1. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma

    Blood, Vol. 110, Núm. 9, pp. 3112-3121

2006

  1. TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells

    Leukemia, Vol. 20, Núm. 3, pp. 505-513

2004

  1. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - A study within the Europe against cancer program [9]

    Leukemia

2003

  1. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936

    Leukemia, Vol. 17, Núm. 12, pp. 2257-2317

  2. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: Immunobiological characteristics and clinical implications

    Leukemia, Vol. 17, Núm. 7, pp. 1398-1403

  3. Standardization and quality control studies of 'real time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program

    Leukemia, Vol. 17, Núm. 12, pp. 2318-2357

2001

  1. Immunoglobulin lambda isotype, gene rearrangements in B cell malignancies

    Leukemia, Vol. 15, Núm. 1, pp. 121-127

1999

  1. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705

  2. Heteroduplex PCR analysis of rearranged immunoglobulin genes for clonality assessment in multiple myeloma

    Haematologica, Vol. 84, Núm. 4, pp. 328-335

  3. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies

    Haematologica, Vol. 84, Núm. 9, pp. 779-784

  4. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

    Leukemia, Vol. 13, Núm. 1, pp. 110-118

  5. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia

    Leukemia